|
Imeik Technology Development Co., Ltd. (300896.SZ) DCF -Bewertung
CN | Healthcare | Medical - Instruments & Supplies | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Imeik Technology Development Co.,Ltd. (300896.SZ) Bundle
Egal, ob Sie ein Investor oder Analyst sind, dieser DCF -Taschenrechner (300896SZ) ist Ihr ultimatives Werkzeug für eine genaue Bewertung. Vorausgestattet mit Imeik Technology Development Co., Ltd. Real Data können Sie Prognosen anpassen und die Auswirkungen sofort beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 557.7 | 709.3 | 1,447.9 | 1,938.8 | 2,869.3 | 4,369.2 | 6,652.9 | 10,130.4 | 15,425.6 | 23,488.5 |
| Revenue Growth, % | 0 | 27.18 | 104.13 | 33.91 | 47.99 | 52.27 | 52.27 | 52.27 | 52.27 | 52.27 |
| EBITDA | 352.1 | 482.2 | 1,142.6 | 1,521.0 | 2,196.7 | 3,189.9 | 4,857.2 | 7,396.1 | 11,262.1 | 17,148.7 |
| EBITDA, % | 63.13 | 67.99 | 78.92 | 78.45 | 76.56 | 73.01 | 73.01 | 73.01 | 73.01 | 73.01 |
| Depreciation | 10.1 | 11.1 | 19.7 | 28.6 | 44.5 | 67.8 | 103.2 | 157.1 | 239.2 | 364.2 |
| Depreciation, % | 1.8 | 1.56 | 1.36 | 1.48 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 | 1.55 |
| EBIT | 342.1 | 471.1 | 1,122.9 | 1,492.3 | 2,152.2 | 3,122.1 | 4,754.1 | 7,239.0 | 11,022.9 | 16,784.5 |
| EBIT, % | 61.33 | 66.43 | 77.56 | 76.97 | 75.01 | 71.46 | 71.46 | 71.46 | 71.46 | 71.46 |
| Total Cash | 505.6 | 4,297.4 | 3,634.1 | 3,843.3 | 3,937.2 | 4,287.5 | 6,528.6 | 9,941.1 | 15,137.3 | 23,049.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 14.7 | 29.8 | 72.4 | 127.8 | 206.1 | 223.8 | 340.8 | 519.0 | 790.3 | 1,203.3 |
| Account Receivables, % | 2.64 | 4.2 | 5 | 6.59 | 7.18 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
| Inventories | 23.3 | 26.8 | 34.9 | 46.7 | 49.8 | 126.8 | 193.1 | 294.0 | 447.7 | 681.7 |
| Inventories, % | 4.18 | 3.78 | 2.41 | 2.41 | 1.73 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 |
| Accounts Payable | 7.4 | 4.6 | 8.5 | 19.3 | 44.7 | 44.7 | 68.1 | 103.7 | 158.0 | 240.5 |
| Accounts Payable, % | 1.33 | 0.64276 | 0.59042 | 0.99734 | 1.56 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 |
| Capital Expenditure | -32.6 | -32.1 | -23.0 | -155.7 | -63.7 | -194.1 | -295.5 | -450.0 | -685.2 | -1,043.4 |
| Capital Expenditure, % | -5.84 | -4.53 | -1.59 | -8.03 | -2.22 | -4.44 | -4.44 | -4.44 | -4.44 | -4.44 |
| Tax Rate, % | 13.78 | 13.78 | 13.78 | 13.78 | 13.78 | 13.78 | 13.78 | 13.78 | 13.78 | 13.78 |
| EBITAT | 297.9 | 412.2 | 958.9 | 1,267.0 | 1,855.6 | 2,691.8 | 4,098.9 | 6,241.3 | 9,503.7 | 14,471.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 244.8 | 369.7 | 908.9 | 1,083.5 | 1,780.4 | 2,470.7 | 3,746.6 | 5,704.9 | 8,686.9 | 13,227.6 |
| WACC, % | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 23,075.5 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 13,691 | |||||||||
| Terminal Value | 184,683 | |||||||||
| Present Terminal Value | 110,031 | |||||||||
| Enterprise Value | 133,107 | |||||||||
| Net Debt | -2,381 | |||||||||
| Equity Value | 135,488 | |||||||||
| Diluted Shares Outstanding, MM | 303 | |||||||||
| Equity Value Per Share | 447.83 |
Benefits You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled financial data for Imeik Technology Development Co., Ltd. (300896SZ).
- Accurate Data Insights: Historical performance data alongside forward-looking projections (highlighted in the yellow cells).
- Adaptable Forecasting: Modify key assumptions such as revenue growth rates, EBITDA margins, and WACC.
- Real-Time Calculations: Instantly assess how your inputs affect the valuation of Imeik Technology Development Co., Ltd. (300896SZ).
- Professional Grade Tool: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Interface: Organized for user friendliness and clarity, complete with step-by-step guidance.
Highlight Features
- Comprehensive Imeik Financials: Gain access to precise pre-loaded historical performance data and future forecasts.
- Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation outcomes.
- Designed for All Levels: An intuitive layout tailored for investors, CFOs, and consultants alike.
How It Functions
- Download the Template: Gain instant access to the Excel-based Imeik Technology DCF Calculator for [300896SZ].
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and additional metrics.
- Instant Calculations: The model will automatically recalculate Imeik Technology’s intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the findings to inform your investment strategy or financial analysis.
Why Choose This Calculator for Imeik Technology Development Co., Ltd. (300896SZ)?
- All-in-One Solution: Features DCF, WACC, and financial ratio analyses conveniently bundled together.
- Adjustable Parameters: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Imeik's intrinsic value and Net Present Value.
- Ready-to-Use Data: Comes with historical and projected data for reliable baseline assessments.
- High-Quality Standards: Perfect for financial analysts, investors, and business consultants.
Who Should Use This Product?
- Investors: Accurately assess Imeik Technology Development Co., Ltd.'s fair value before making investment choices in (300896SZ).
- CFOs: Utilize a professional-grade DCF model for financial analysis and reporting related to (300896SZ).
- Consultants: Efficiently customize the template for valuation reports tailored to clients involved with (300896SZ).
- Entrepreneurs: Discover insights into financial modeling practices utilized by leading companies in the industry, including (300896SZ).
- Educators: Employ it as a resource for teaching valuation techniques, particularly in relation to (300896SZ).
Contents of the Template
- Pre-Filled DCF Model: Imeik Technology Development Co.,Ltd.'s financial data preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Imeik's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and capital expenditures to suit your scenarios.
- Financial Statements: Annual and quarterly reports to support in-depth analysis.
- Interactive Dashboard: Effortlessly visualize key valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.